Cross-country analysis of national mental health investment case studies in sub-Saharan Africa and Central, South and South-East Asia.

benefit-cost global health health financing mental health return on investment

Journal

Frontiers in health services
ISSN: 2813-0146
Titre abrégé: Front Health Serv
Pays: Switzerland
ID NLM: 9918334887706676

Informations de publication

Date de publication:
2023
Historique:
received: 30 04 2023
accepted: 04 07 2023
medline: 3 8 2023
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: epublish

Résumé

Despite the increasing interest in and political commitment to mental health service development in many regions of the world, there remains a very low level of financial commitment and corresponding investment. Assessment of the projected costs and benefits of scaling up the delivery of effective mental health interventions can help to promote, inform and guide greater investment in public mental health. A series of national mental health investment case studies were carried out (in Bangladesh, Kenya, Nepal, Philippines, Uganda, Uzbekistan and Zimbabwe), using standardized guidance developed by WHO and UNDP and implemented by a multi-disciplinary team. Intervention costs and the monetized value of improved health and production were computed in national currency units and, for comparison, US dollars. Benefit-cost ratios were derived. Across seven countries, the economic burden of mental health conditions was estimated at between 0.5%-1.0% of Gross Domestic Product. Delivery of an evidence-based package of mental health interventions was estimated to cost US$ 0.40-2.40 per capita per year, depending on the country and its scale-up period. For most conditions and country contexts there was a return of >1 for each dollar or unit of local currency invested (range: 0.0-10.6 to 1) when productivity gains alone are included, and >2 (range: 0.4-30.3 to 1) when the intrinsic economic value of health is also considered. There was considerable variation in benefit-cost ratios between intervention areas, with population-based preventive measures and treatment of common mental, neurological and conditions showing the most attractive returns when all assessed benefits are taken into account. Performing a mental health investment case can provide national-level decision makers with new and contextualized information on the outlays and returns that can be expected from renewed local efforts to enhance access to quality mental health services. Economic evidence from seven low- and middle-income countries indicates that the economic burden of mental health conditions is high, the investment costs are low and the potential returns are substantial.

Identifiants

pubmed: 37533704
doi: 10.3389/frhs.2023.1214885
pmc: PMC10392930
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1214885

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© 2023 Chisholm, Lee, Baral, Bhagwat, Dombrovskiy, Grafton, Kontsevaya, Huque, Kalani Okware, Kulikov, Marahatta, Mavunganidze, Omar, Prasai, Putoud, Tsoyi and Vergara.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Lancet Glob Health. 2021 Mar;9(3):e291-e300
pubmed: 33341152
BMJ. 2012 Mar 02;344:e609
pubmed: 22389339
World Psychiatry. 2020 Feb;19(1):3-14
pubmed: 31922693
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Lancet. 2013 Dec 7;382(9908):1898-955
pubmed: 24309475
Epidemiol Psychiatr Sci. 2023 Jul 12;32:e46
pubmed: 37434513
BMJ Glob Health. 2022 Jun;7(6):
pubmed: 35705224
Mol Psychiatry. 2011 Dec;16(12):1234-46
pubmed: 20938433
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119

Auteurs

Dan Chisholm (D)

Department of Mental Health and Substance Use, World Health Organization (WHO), Geneva, Switzerland.

Yong Yi Lee (YY)

Health Economics Division, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
School of Public Health, The University of Queensland, Brisbane, QLD, Australia.
Queensland Centre for Mental Health Research, Brisbane, QLD, Australia.

Phanindra Prasad Baral (PP)

Epidemiology and Disease Control Division, Ministry of Health and Population, Kathmandu, Nepal.

Sadhana Bhagwat (S)

WHO Country Office, Dhaka, Bangladesh.

Vladislav Dombrovskiy (V)

Center for Healthcare Quality Assessment and Control, Moscow, Russia.

Daniel Grafton (D)

United Nations Development Programme, Istanbul, Turkey.

Anna Kontsevaya (A)

National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia.

Rumana Huque (R)

Department of Economics, University of Dhaka, Dhaka, Bangladesh.

Kenneth Kalani Okware (K)

Mental Health Division, Ministry of Health, Kampala, Uganda.

Alexey Kulikov (A)

United Nations Inter-Agency Task Force on the Prevention and Control of NCDs, Geneva, Switzerland.

Kedar Marahatta (K)

WHO Country Office, Kathmandu, Nepal.

Patience Mavunganidze (P)

Mental Health Department, Ministry of Health and Child Care, Harare, Zimbabwe.

Nasri Omar (N)

Division of Mental Health, Ministry of Health, Nairobi, Kenya.

Devi Prasai (D)

Nepal Development Research Institute, Kathmandu, Nepal.

Nadia Putoud (N)

United Nations Inter-Agency Task Force on the Prevention and Control of NCDs, Geneva, Switzerland.

Elena Tsoyi (E)

Division of Country Health Programmes, WHO Regional Office for Europe, Copenhagen, Denmark.

Jasmine Vergara (J)

WHO Country Office, Manila, Philippines.

Classifications MeSH